Vincerx Pharma Inc

+0.04 (+2.48%)
Earnings Announcements

Vincerx Pharma Posts Quarterly Loss Per Share $0.31

Published: 03/29/2022 12:16 GMT
Vincerx Pharma Inc (VINC) - Vincerx Pharma Reports Fourth Quarter and Full Year 2021 Financial Results and Provides a Corporate Update.
Expected Cash Runway Through 2023.
Had $111.5 Million in Cash As of December 31, 2021, As Compared to $61.8 Million As of December 31, 2020.
Qtrly Loss per Share $0.31.
Q4 Revenue View $0.00 -- Refinitiv Ibes Data (analyst estimates).
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.95

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.97

More details on our Analysts Page.